What is Go Sober?
Go Sober, LLC operates at the intersection of neuroscience, pharmacology, and behavioral science to redefine the landscape of alcohol dependency treatment. Unlike traditional institutional models, the company provides a comprehensive, in-home medical outpatient program that prioritizes personalized care. By addressing the physiological and psychological drivers of alcoholism, Go Sober enables clients to achieve long-term sobriety through a multidisciplinary framework. Their market position is bolstered by a commitment to evidence-based interventions, allowing individuals to navigate recovery without the disruption of residential facility stays, thereby increasing accessibility and adherence to treatment protocols.
How much funding has Go Sober raised?
Go Sober has raised a total of $63K across 1 funding round:
Debt
$63K
Debt (2021): $63K with participation from PPP
Key Investors in Go Sober
PPP
Public-Private Partnership
What's next for Go Sober?
With the infusion of this latest financing, Go Sober is entering a critical phase of operational scaling. The company is expected to prioritize the expansion of its clinical network and the enhancement of its digital health infrastructure to support a broader patient base. Strategic focus will likely remain on refining its behavioral modification algorithms and strengthening its pharmacological support systems. As the firm matures through its Series B/C stage, the objective is to solidify its footprint in the telehealth-enabled addiction recovery sector, potentially exploring partnerships with insurance providers to further integrate its specialized care model into the mainstream healthcare ecosystem.
See full Go Sober company page
